Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant

This study is currently recruiting participants.

Verified May 2013 by Roswell Park Cancer Institute

Sponsor:

Information provided by (Responsible Party):

Roswell Park Cancer Institute

ClinicalTrials.gov Identifier:

NCT00534118

First received: September 20, 2007

Last updated: May 30, 2013

Last verified: May 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	September 2013 (Final data collection date for primary outcome measure)